Retaglutide is a cutting-edge GLP-1 receptor agonist currently under study for the management of metabolic disorders. This medication works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally https://jimdfsg855761.free-blogz.com/86285156/trelaglutide-exploring-a-new-therapy-for-chronic-diseases